Plasma cell dyscrasia and Iatrogenic infection (expanded source)


Iatrogenic infection is reported only by a few people with Plasma cell dyscrasia. We study 2 people who have Iatrogenic infection and Plasma cell dyscrasia from FDA and eHealthme. Find out below who they are, other conditions they have and drugs they take.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.



On Aug, 21, 2018

2 people who have Plasma Cell Dyscrasia and Iatrogenic Infection are studied.


Number of reports submitted per year:

Would you have Iatrogenic infection when you have Plasma cell dyscrasia?

Gender of people who have Plasma Cell Dyscrasia and experience Iatrogenic Infection *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Plasma Cell Dyscrasia and experience Iatrogenic Infection *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Most common drugs for these people *:

  1. Velcade: 2 people, 100.00%
  2. Dexamethasone: 2 people, 100.00%
Check whether a drug or a condition causes Iatrogenic infection

Top symptoms for these people *:

  1. Mucosal Inflammation (infection of mucous membrane): 2 people, 100.00%
  2. Urinary Tract Infection: 1 person, 50.00%
  3. Encephalitis (inflammation of the brain): 1 person, 50.00%
  4. Agitation (state of anxiety or nervous excitement): 1 person, 50.00%
  5. Colitis (inflammation of colon): 1 person, 50.00%
  6. Confusion: 1 person, 50.00%
  7. Confusional State: 1 person, 50.00%
  8. Drowsiness: 1 person, 50.00%
  9. Drug Eruption (adverse drug reaction of the skin): 1 person, 50.00%
  10. Dysglobulinaemia (abnormality of the amount or quality of blood globulins): 1 person, 50.00%
Click here to get more results

* Approximation only. Some reports may have incomplete information.

Are you new to Plasma cell dyscrasia or have questions?

Volunteer or get paid to help people with your care experience




Related studies


Plasma Cell Dyscrasia

Plasma cell dyscrasia (cancers of the plasma cells) can be treated by Revlimid, Velcade, Dexamethasone, Zometa, Thalomid (latest reports from 180,718 Plasma cell dyscrasia patients)

Iatrogenic Infection

Iatrogenic infection (complication as a result of treatment) has been reported by people with chronic kidney disease, pyoderma gangrenosum, multiple myeloma, fever, mantle cell lymphoma (latest reports from 56 Iatrogenic infection patients).


Drugs that are associated with Iatrogenic infection
Iatrogenic infection (66 drugs)
Other conditions that could cause Iatrogenic infection
Iatrogenic infection (44 conditions)
Browse all symptoms of Plasma cell dyscrasia
a b c d e f g h i j k l m n o p q r s t u v w x y z

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Plasma cell dyscrasia, Iatrogenic infection

Recent updates

General studies

You could also:

  • Print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.